Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Ware

Showing results (201-210 of 273) with videos related to

Pageof 28
Sort By:
Bioorganic & Medicinal Chemistry|July 22, 2011
N-alkylated cyclen cobalt(III) complexes of 1-(chloromethyl)-3-(5,6,7-trimethoxyindol-2-ylcarbonyl)-2,3-dihydro-1H-pyrrolo[3,2-f]quinolin-5-ol DNA alkylating agent as hypoxia-activated prodrugsGuo-Liang Lu, Ralph J Stevenson, John Yu-Chih Chang, et al.
Health Education Research|February 25, 2026
Predictors of enrollment and cessation outcomes in a telehealth opt-out tobacco treatment programVincent S Anokye, Avery Roberson, Amanda Palmer, et al.
Journal of Medicinal Chemistry|October 14, 2009
Synthesis and evaluation of stable bidentate transition metal complexes of 1-(chloromethyl)-5-hydroxy-3-(5,6,7-trimethoxyindol-2-ylcarbonyl)-2,3-dihydro-1H-pyrrolo[3,2-f]quinoline (seco-6-azaCBI-TMI) as hypoxia selective cytotoxinsJared B J Milbank, Ralph J Stevenson, David C Ware, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 24, 2012
What's love got to do with it? Explaining adherence to oral antiretroviral pre-exposure prophylaxis for HIV-serodiscordant couplesNorma C Ware, Monique A Wyatt, Jessica E Haberer, et al.
JAMA Network Open|May 8, 2026
Medication Samples and Smoking Cessation Among Adults: A Randomized Clinical TrialMatthew J Carpenter, Tracy T Smith, Amy E Wahlquist, et al.
AIDS and Behavior|March 7, 2020
Influences on Adherence to Antiretroviral Therapy (ART) in Early-Stage HIV Disease: Qualitative Study from Uganda and South AfricaNorma C Ware, Monique A Wyatt, Emily E Pisarski, et al.
Diagnostics (Basel, Switzerland)|January 11, 2024
"<i>It Soothes Your Heart</i>": A Multimethod Study Exploring Acceptability of Point-of-Care Viral Load Testing among Ugandan Pregnant and Postpartum Women Living with HIVAgnes Nakyanzi, Faith Naddunga, Michelle A Bulterys, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 14, 2013
CD160 activation by herpesvirus entry mediator augments inflammatory cytokine production and cytolytic function by NK cellsJohn R Šedý, Ryan L Bjordahl, Vasileios Bekiaris, et al.
AIDS and Behavior|April 20, 2017
The Technology Acceptance Model for Resource-Limited Settings (TAM-RLS): A Novel Framework for Mobile Health Interventions Targeted to Low-Literacy End-Users in Resource-Limited SettingsJeffrey I Campbell, Isaac Aturinda, Evans Mwesigwa, et al.
Journal of the International AIDS Society|January 19, 2019
Beyond HIV prevention: everyday life priorities and demand for PrEP among Ugandan HIV serodiscordant couplesEdith Nakku-Joloba, Emily E Pisarski, Monique A Wyatt, et al.
Pageof 28

Showing results (201-210 of 273) with videos related to

Sort By:
Pageof 28
Bioorganic & Medicinal Chemistry|July 22, 2011
N-alkylated cyclen cobalt(III) complexes of 1-(chloromethyl)-3-(5,6,7-trimethoxyindol-2-ylcarbonyl)-2,3-dihydro-1H-pyrrolo[3,2-f]quinolin-5-ol DNA alkylating agent as hypoxia-activated prodrugsGuo-Liang Lu, Ralph J Stevenson, John Yu-Chih Chang, et al.
Health Education Research|February 25, 2026
Predictors of enrollment and cessation outcomes in a telehealth opt-out tobacco treatment programVincent S Anokye, Avery Roberson, Amanda Palmer, et al.
Journal of Medicinal Chemistry|October 14, 2009
Synthesis and evaluation of stable bidentate transition metal complexes of 1-(chloromethyl)-5-hydroxy-3-(5,6,7-trimethoxyindol-2-ylcarbonyl)-2,3-dihydro-1H-pyrrolo[3,2-f]quinoline (seco-6-azaCBI-TMI) as hypoxia selective cytotoxinsJared B J Milbank, Ralph J Stevenson, David C Ware, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 24, 2012
What's love got to do with it? Explaining adherence to oral antiretroviral pre-exposure prophylaxis for HIV-serodiscordant couplesNorma C Ware, Monique A Wyatt, Jessica E Haberer, et al.
JAMA Network Open|May 8, 2026
Medication Samples and Smoking Cessation Among Adults: A Randomized Clinical TrialMatthew J Carpenter, Tracy T Smith, Amy E Wahlquist, et al.
AIDS and Behavior|March 7, 2020
Influences on Adherence to Antiretroviral Therapy (ART) in Early-Stage HIV Disease: Qualitative Study from Uganda and South AfricaNorma C Ware, Monique A Wyatt, Emily E Pisarski, et al.
Diagnostics (Basel, Switzerland)|January 11, 2024
"<i>It Soothes Your Heart</i>": A Multimethod Study Exploring Acceptability of Point-of-Care Viral Load Testing among Ugandan Pregnant and Postpartum Women Living with HIVAgnes Nakyanzi, Faith Naddunga, Michelle A Bulterys, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 14, 2013
CD160 activation by herpesvirus entry mediator augments inflammatory cytokine production and cytolytic function by NK cellsJohn R Šedý, Ryan L Bjordahl, Vasileios Bekiaris, et al.
AIDS and Behavior|April 20, 2017
The Technology Acceptance Model for Resource-Limited Settings (TAM-RLS): A Novel Framework for Mobile Health Interventions Targeted to Low-Literacy End-Users in Resource-Limited SettingsJeffrey I Campbell, Isaac Aturinda, Evans Mwesigwa, et al.
Journal of the International AIDS Society|January 19, 2019
Beyond HIV prevention: everyday life priorities and demand for PrEP among Ugandan HIV serodiscordant couplesEdith Nakku-Joloba, Emily E Pisarski, Monique A Wyatt, et al.
Pageof 28